The efficacy and safety of continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) in pregnant women with type 1 diabetes mellitus

Preview format:

Object preview unavailable

We use files, through the cookie quality improvement layer of our website.For more information, please read the document